Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
8
×
boston blog main
8
×
boston top stories
national blog main
life sciences
boston
national top stories
san francisco blog main
deals
san francisco top stories
san diego blog main
startups
fda
investing
medical devices
new york blog main
san diego top stories
vc
clinical trials
dna
new york top stories
san francisco
seattle blog main
venture capital
acetylon pharmaceuticals
agios therapeutics
ambys medicines
arrowmark partners
atrial fibrillation
azacitidine
base editing
bay state health
beta bionics
beta-thalassemia
bigfoot biomedical
biobucks
biofourmis
biovotion
boston scientific
boston university
What
startup
8
×
therapeutics
million
adding
biotech
boston
deal
developing
device
medicines
new
patients
acquire
aiming
aims
ambys
analytics
approach
atrial
based
beam
beta
bets
big
biofourmis
bionics
blood
boost
business
called
cancer
cas
censinet
closed
continues
control
crispr
cryterion
cyber
data
Language
unset
Current search:
biotech
×
" boston blog main "
×
startup
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Censinet Takes Off With $7.8M to Track Cyber Risks in Healthcare
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M